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Background: Malaria is associated with an increase in HIV viral load and a fall in CD4-cell count. Conversely, HIV
infection disrupts the acquired immune responses to malaria and the efficacy of antimalarial drugs. This study was
carried out in five Ghanaian hospitals to estimate the prevalence of clinically confirmed malaria among HIV patients
by evaluating their hospital records.
Methods: This retrospective descriptive cross sectional study reviewed and collected data on malaria, using Case
Record Forms from HIV patients’ folders in five hospitals in Ghana.
Results: There were 933 patients records made up of 272 (29.2%) males and 661 (70.8%) females. Majority of the
patients were aged between 21–40 (63.6%) years and the rest were between the ages 1–20 (2.8%) years, 41–60
(31.6%) years and 61–80 (2.1%) years of age.
A total of 38.1% (355/933) of the patients were clinically suspected of having clinical malaria. Of these 339 (95.5%)
were referred to the laboratory for confirmation of the diagnosis of malaria. Only 4.4% (15/339) of patients tested
were confirmed as cases of malaria among the patients that were clinically suspected of having malaria and
subsequently confirmed. Fever, was not significantly associated with a confirmed diagnosis of malaria [OR = 3.11,
95% CI: (0.63, 15.37), P = 0.142].
Conclusions: There was a 4.4% prevalence of confirmed malaria and 38.1% of presumptively diagnosed malaria
from the case records of HIV patients from the selected hospitals in Ghana.Background
Africa has a heavy burden of HIV and malaria infections
[1,2], two diseases which are the common infections in
sub-Saharan Africa [1]. Over 200–500 million episodes of
malaria occur yearly worldwide [3,4] and malaria remains
the first cause of loss of days of healthy life in Ghana [5].
Malaria could have possible effects on HIV acquisition,
disease progression, and response to therapy [6]. There
may be a temporary increase in HIV-RNA and a decrease
in CD4-T-lymphocyte count due to other infections as
well as to malaria infections.
Malaria is known to be associated with an increase in
viral load as noted in a study by Chalwe et al. in Zambia* Correspondence: adugyasidennis@yahoo.co.uk
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reproduction in any medium, provided the orwhere HIV infected individuals with malaria had signifi-
cant increase in viral load [7] and a fall in CD4-cell
count [8], which could pose a potential threat in the clinical
course of people with HIV infection [9]. This phenomenon
is more severe in HIV infected adults [10]. Conversely, HIV
infection could also disrupt the acquired immune response
to malaria; affect the incidence, the frequency and severity
of malaria and the efficacy of anti-malarial drugs [11-13].
There are concerns that in malaria endemic areas where
HIV prevalence is high interactions with antiretroviral
therapy (ART) especially protease inhibitors could affect
the utilization of newly introduced artemisinin-based
combination therapy (ACT), though this finding was estab-
lished in a small study [14]. In some cases administration of
anti-malarial with anti-retroviral drugs have led to various
levels of toxicity due to some effects of HIV-specific factors
and drug interactions [15,16].ral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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has an estimated 336,000 people living with HIV [17] with
considerable variations in various regions of the country
[18]. Nearly all regions of Ghana are malaria-endemic with
transmission being all year-round. Significant variations
however exist in the months of peak incidence of mal-
aria transmission. The crude parasite rates in Ghanaian
general population range from 10-70%, with Plasmodium
falciparum accounting for 90-98% of all infections [19].
The average prevalence of malaria in all age cohorts
was given as 58% in a study by Owusu-Agyei et al. con-
ducted in the Kintampo North and South Districts of
the Brong-Ahafo Region of Ghana in 2009 [20].
Due to the fact that statistics for the prevalence of
malaria among HIV patients is not readily available it
became necessary to carry out this study in five hospitals
within the Brong-Ahafo and Ashanti Regions of Ghana
to establish the prevalence of confirmed malaria using
case records of HIV patients registered in the hospitals
to receive HIV management and care.
Methods
Study clinics/sites
The facilities used for the study were the Kintampo
Municipal Hospital in the Kintampo North Municipality,
the Holy Family Hospital in the Techiman Municipality
and the Sunyani Regional Hospital all in the Brong-Ahafo
Region. Other facilities were used in the Ashanti Region
of Ghana and these were St Patrick’s Hospital in the
Offinso South Municipality and the Agogo Presbyterian
Hospital, in the Asante Akim District. These health facilities
were selected for the study because they offered HIV/AIDS
management clinics and services (Figure 1) and played
significant roles in the management of nearly 35% of HIV
patients within the two regions of Ghana [18]. Information
on HIV patients from the selected sites is representative
of the larger population of HIV patients, their manage-
ment practices and record keeping are similar to the other
facilities in the public hospitals in the other regions of
Ghana [21]. Scheduled follow-up visits of patients were
made based on patient’s severity of illness and also pa-
tient’s records of adherence to management therapy.
This was found to be a maximum of every two months.
The data collection was carried out in July 2010.
Study design and procedure
The study was a retrospective and descriptive cross-
sectional study. Hospital records of registered seropositive
patients attending HIV clinics, from five HIV management
sites within Ghana Health Service were selected and ran-
domly reviewed to collect data on malaria cases and HIV,
for a one year period following the patient’s registration in
each facility. Patients’ registration numbers were used in
each facility to randomly select their hospital folders tostart the selection process for the review. Total number of
folders selected from each facility was based on the total
registered patients in each facility based on their date of
attendance and how they could potentially contribute to
the study (Figure 2).
Definitions used at data collection
Malaria: A case of malaria needed to have been confirmed
by the laboratory. A laboratory confirmed cases of malaria
was based on either a blood slide reading or the use of
rapid diagnostic test (RDT) kits.
Episode: An episode of malaria was defined as a re-
ported case from a patient who was examined and
found to be indeed a case of malaria and treated.
Data collection
Data collected from the patients’ folders included; the
dates of registration in each facility, patient’s age, sex
and socio-demographic information. Other informa-
tion collected were information on fever and episodes
of malaria as well as confirmed diagnosis of malaria. A
case record form (CRF) was designed for extraction of
the data based on the template used at the HIV man-
agement clinics. The category of patients’ folders ex-
cluded from review were those who had defaulted on
their schedule visits for three or more consecutive
times. Data of such individuals were excluded because
it would have affected the overall quality of the data
and the generalizability of the data.
HIV diagnosis
HIV diagnosis in each of the facilities was carried out by
antibody testing using either First Response HIV 1–2, Rapid
HIV Test kit (Premier Medical Corporation Limited, India)
or Determine HIV-1/2 test kit (Abbott Laboratories,
USA). The test was further confirmed with Ora Quick
Rapid HIV-1/2 Antibody Test (OraSure Technologies,
Inc, USA). An immunoblot assay, Innolia HIV 1&2
(Innogenetics, N.V. Belgium) was used for clarification
of discordant results [21] both at the Tertiary hospitals
and the Public Health Reference Laboratories.
Malaria diagnosis
Malaria cases which were included were based on treated
malaria cases either with or without laboratory diagnosis.
In the hospitals, blood slide reading for malaria diagnosis
was made as follows. A thick blood film was made on a
microscope slide and stained with 10% Giemsa for ten
(10) minutes. Parasite diagnosis and quantification,
using a light microscope, was made using the plus system
by WHO (“+”, “++”, “+++”, and “++++”). A standard
operating procedure (SOP) was developed and used
across the sites. In some laboratories Rapid Diagnostic
Test (RDT) kits were used to diagnose malaria. Data
Figure 1 The map of Ghana with the regions and towns of the health facilities that were used for the review were selected.
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with either blood slide reading or RDT were however
not available.To minimize selection bias, an equal proportion of
patients’ folders of HIV patients registered in each of
the five selected facilities were reviewed.
Figure 2 Flow chart for the selection of folders for the malaria in HIV study.
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Data was collected from each of the HIV treatment cen-
tres in accordance with Good Clinical Practices (GCP).
Ethical approvals for the study were given by the Ghana
Health Service Ethical Review Committee, the Kintampo
Health Research Centre Institutional Ethics Considering
that the study involved secondary data analyses, an ap-
plication was made for ethical approvals from the eth-
ics committees for a waiver for each individual patient
to give informed consent. Permission was also sought
from the National AIDS/STI Control Programme, the
Ghana AIDS Commission and the Managers of the
various facilities selected for the study.
Quality control
Ten per cent (10%) of all folders reviewed in each facility
were verified and checked using the patients’ folders and
the CRFs that had been filled. All CRFs were checked
on-site to ensure missing data or blanks were not the result
of errors made during data collection but actually existed
as blanks in patients’ folders.
Data management and strategy for data analysis
Microsoft Access 2007 data management software and
Stata 11 software (Stata Corporation, TX USA) wereused for data entry and data analyses respectively.
Verification and consistency checks were performed
with reference to the Case Record Forms. Multivariate
logistic regression models were used to adjust for probable
confounding factors.
Results
Demographic and social characteristics
A total of 933 patients’ folders were reviewed from the five
hospitals. The Presbyterian Hospital in Agogo contributed
(8.5%), St. Patrick’s Hospital in Offinso (16.1%), Kintampo
Municipal Hospital (8.6%), Holy Family Hospital, Techiman
(19.8%) and Sunyani Regional Hospital (47.1%).
Of the 933 patients, 272 (29.2%) were males and 661
(70.8%) were females. Patients enrolled into the study and
with no missing records of age were made of ages 1–20
(2.8%) years, 41–60 (31.6%) years, 61–80 (2.1%) years.
Majority of them were aged between 21–40 (63.6%)
years. Included in the folders reviewed were records of
1.2% (11/933) children with their ages less than 10 years.
Data of the patients’ weights at enrolment were present
in 834 (89.4%) folders and missing in 99 (10.6%). Records
for both age and weight of patients at enrolment, were
available for 780 patients (83.6%). The mean weight (S.D)
at enrolment was 53.0 kg (12.0) for males and 51.0 kg
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excluded during data analyses.
Overall, 627 (67.2%) of the 933 patients were on anti-
retroviral therapy in the period under review and 89%
(558/627) were compliant in their drug-use. There were
no information about the HIV-RNA of the patients.
Malaria prevalence
In the 933 folders reviewed, 355 (38.1%) reported a
diagnosis of clinical malaria out of which 339 (95.5%)
were referred to the laboratory for confirmation. Only
15 patients were confirmed as positive, representing
4.4%. Nevertheless, all 355 patients were given anti-malarial
treatment. There was no significant association between
confirmed malaria cases and age groups of patients
(p = 0.499) neither was there any association between
diagnosis and weights (p = 0.386) at enrolment.
Malaria and ART status
Of the 15 confirmed malaria cases, 13 (86.7%) were on
ART; and the remaining 2 (13.3%) were not on ART.
There was no significant difference between patients who
were on ART and had malaria and those not on ART but
had malaria [OR = 2.42, 95% CI: (0.53, 11.02), P = 0.237].
However, the number of cases remains few and any
interpretation should be made with caution. However,
considering malaria diagnosed presumptively, expectedly
248/614 (40.4%) of patients on ART were diagnosed
with clinical malaria as compared to 92/304 (30.3%) of
those who were not on ART but had clinical malaria
[OR = 1.56, 95% CI: (1.16, 2.10), P = 0.003]. Malaria was
over-diagnosed based on the presence of fever (OR = 4.11,
95% CI: [2.83, 5.96], P < 0.001).
Discussion
Following the review of the clinical records, the study
recorded 4.4% (95% CI: 2.2, 6.6) prevalence of laboratory
confirmed malaria and 38.1% (95% CI: 34.9, 41.2) of
malaria diagnosed purely by clinical signs and symptoms
among HIV patients in the two regions of Ghana. This











n (%) n (%)
<21 12 (5.4) 26.7 (19.4) 8 (1.4) 50.6 (9.4)
21-40 90 (40.5) 54.3 (8.8) 404 (72.4) 51.5 (9.8)
41-60 114 (51.4) 54.8 (10.2) 135 (24.2) 49.8 (10.6)
61-80 6 (2.7) 51.1 (8.7) 11 (2.0) 48.3 (8.7)
Total (N = 780) 222 (28.5) 53.0 (12.0) 558 (71.5) 51.0 (10.0)
Records not available for both initial weight and age: 153/933.prevalence of 5.8% of HIV-Malaria co-infection recorded
by Tshikuka et al. [22] and clinically captured malaria
compared to records established by Owusu-Agyei et al.
Though it has been established in this study that the
practice of presumptive diagnosis of malaria is high 38.1%,
one would have still expected a high prevalence of con-
firmed malaria among a population with known immune
suppression [23-25]. A low prevalence of malaria compared
to the prevalence obtained by presumptive diagnosis among
HIV patients on co-trimoxazole prophylaxis (COT) could
confirm the protective effect of COT against malaria [10].
One interesting finding was that, there was no significant
difference in the prevalence of malaria among patients
who were on ART and those who were not. However,
there was an increased risk of being diagnosed with con-
firmed cases of malaria if one was on ART, though this was
not statistically significant [OR = 2.42, 95% CI: (0.53, 11.02),
P = 0.237]. This could be attributed to an observation that
was made that most HIV patients started attending ART
clinics when their CD4 counts were below the cut-off
points to be considered eligible for treatment. Such patients
were often sick and frail and at such level of immunosup-
pression without COT, it is not surprising they would be
exposed to an increased risk to malaria. The study could
not adjust for protective effect of use of COT prophylaxes
since almost all the patients took COT.
Fever is the most widely recognized manifestation of mal-
aria. Fever may also be caused by HIV itself, opportunistic
infections, or adverse drug reaction [26-28]. Several studies
of the causes of fever in HIV-infected persons living in
regions of stable malaria transmission have found that the
majority of episodes of fever are not caused by malaria
[28-30]. In this study, malaria was over-diagnosed based on
the presence of fever (OR = 4.11). Since malaria was over-
diagnosed based on fever, HIV patients were likely to have
other illnesses misdiagnosed and treated as malaria [29].
It is also possible that the diagnostic practices adopted
by healthcare providers in the various facilities could also
account for the low confirmed cases of malaria. Most pa-
tients who reported with suspected malaria were not re-
ferred to the laboratory for confirmation of the diagnosis
but were presumptively treated. Data for the proportions
of laboratory confirmations made with either blood slide
reading or RDT were not available.
Patients registered in the facilities were mainly referred
through the Prevention of Mother-To-Child Transmission
(PMTCT) programme and Voluntary Counselling and
Testing (VCT). Observation from the sites revealed that
men were more likely to hide their HIV status since they
could not stand the stigma from the community they lived.
Most of the men apart from the diagnostic processes
were identified and registered after they were invited to
the facilities during counselling of their spouses before
administering their ARTs. This could account for the
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randomly selected for review.
Limitations of study
There was the possibility of sampling bias. Counterpart
records should have been reviewed among HIV negative
patients. Time was not weighted in the analysis. Evaluation
for the records of all participants were carried out over a
one year review period without considering rainy versus
dry seasons. The number of positive cases were not enough
to enable such analyses.
Another major limitation identified in this study was
the high levels of missing data. There were about 3.5%
of patients’ initial CD4 count missing and 32.9% of patients’
fever records, due to poor record keeping. There was also
the possibility that there were other cases of malaria among
the patients which had not been reported to the hospital
and therefore did not appear in their records because they
might have sought for treatment from drug sellers. The
introduction of the National Health Insurance Scheme
and the provision of free medical care for HIV patients
in health facilities could have led to an increase in hospital
attendance [31,32].
Conclusions
The prevalence of confirmed malaria compared to patients
managed presumptively for cases of malaria among HIV
seropositive patients from the selected sites were 4.4% and
38.1% respectively. The study revealed an over-diagnosis
of malaria based on reports of fever raising the possibility
that other conditions which present with fever might go
untreated. With the introduction of RDTs in many health
facilities, confirmation of malaria before treatment should
be encouraged at all levels of patient management.
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